170 related articles for article (PubMed ID: 2003306)
1. Effects of tirilazad mesylate on postischemic brain lipid peroxidation and recovery of extracellular calcium in gerbils.
Hall ED; Pazara KE; Braughler JM
Stroke; 1991 Mar; 22(3):361-6. PubMed ID: 2003306
[TBL] [Abstract][Full Text] [Related]
2. Effects of the lipid peroxidation inhibitor tirilazad mesylate (U-74006F) on gerbil brain eicosanoid levels following ischemia and reperfusion.
Andrus PK; Taylor BM; Sun FF; Hall ED
Brain Res; 1994 Oct; 659(1-2):126-32. PubMed ID: 7820653
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in postischemic neuronal necrosis in gerbils.
Hall ED; Pazara KE; Linseman KL
J Cereb Blood Flow Metab; 1991 Mar; 11(2):292-8. PubMed ID: 1997500
[TBL] [Abstract][Full Text] [Related]
4. Tirilazad mesylate protects vitamins C and E in brain ischemia-reperfusion injury.
Sato PH; Hall ED
J Neurochem; 1992 Jun; 58(6):2263-8. PubMed ID: 1573405
[TBL] [Abstract][Full Text] [Related]
5. Dose-response analysis of the effect of 21-aminosteroid tirilazad mesylate (U-74006F) upon neurological outcome and ischemic brain damage in permanent focal cerebral ischemia.
Park CK; Hall ED
Brain Res; 1994 May; 645(1-2):157-63. PubMed ID: 8062078
[TBL] [Abstract][Full Text] [Related]
6. 21-Aminosteroid lipid peroxidation inhibitor U74006F protects against cerebral ischemia in gerbils.
Hall ED; Pazara KE; Braughler JM
Stroke; 1988 Aug; 19(8):997-1002. PubMed ID: 3400111
[TBL] [Abstract][Full Text] [Related]
7. The use of salicylate hydroxylation to detect hydroxyl radical generation in ischemic and traumatic brain injury. Reversal by tirilazad mesylate (U-74006F).
Althaus JS; Andrus PK; Williams CM; VonVoigtlander PF; Cazers AR; Hall ED
Mol Chem Neuropathol; 1993 Oct; 20(2):147-62. PubMed ID: 8297419
[TBL] [Abstract][Full Text] [Related]
8. The 21-aminosteroid tirilazad mesylate protects against liver injury via membrane stabilization not inhibition of lipid peroxidation.
Wang Y; Mathews WR; Guido DM; Jaeschke H
J Pharmacol Exp Ther; 1996 May; 277(2):714-20. PubMed ID: 8627550
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of impaired cerebral metabolism after severe acidotic ischemia by tirilazad posttreatment in dogs.
Kim H; Koehler RC; Hurn PD; Hall ED; Traystman RJ
Stroke; 1996 Jan; 27(1):114-21. PubMed ID: 8553386
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal lazaroid U78517F in models of focal and global ischemia.
Hall ED; Pazara KE; Braughler JM; Linseman KL; Jacobsen EJ
Stroke; 1990 Nov; 21(11 Suppl):III83-7. PubMed ID: 2237990
[TBL] [Abstract][Full Text] [Related]
11. Tirilazad treatment does not decrease early brain injury after transient focal ischemia in cats.
Takeshima R; Kirsch JR; Koehler RC; Traystman RJ
Stroke; 1994 Mar; 25(3):670-6. PubMed ID: 8128524
[TBL] [Abstract][Full Text] [Related]
12. Tirilazad reduces cortical infarction after transient but not permanent focal cerebral ischemia in rats.
Xue D; Slivka A; Buchan AM
Stroke; 1992 Jun; 23(6):894-9. PubMed ID: 1595111
[TBL] [Abstract][Full Text] [Related]
13. Tirilazad prevention of reperfusion edema after focal ischemia in cynomolgus monkeys.
Boisvert DP; Hall ED
Can J Neurol Sci; 1996 Feb; 23(1):46-52. PubMed ID: 8673962
[TBL] [Abstract][Full Text] [Related]
14. Cyclophosphamide is neuroprotective in a gerbil model of transient severe focal cerebral ischemia: correlation with effects of tirilazad mesylate (U-74006F).
Williams LR; Oostveen JA; Hall ED; Jolly RA; Satoh PS; Petry TW
J Neurotrauma; 1996 Feb; 13(2):103-13. PubMed ID: 9094381
[TBL] [Abstract][Full Text] [Related]
15. Effect of 21-aminosteroid U-74006F on lipid peroxidation in subarachnoid clot.
Kanamaru K; Weir BK; Simpson I; Witbeck T; Grace M
J Neurosurg; 1991 Mar; 74(3):454-9. PubMed ID: 1993911
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of tirilazad mesylate and metabolite U-89678 against blood-brain barrier damage after subarachnoid hemorrhage and lipid peroxidative neuronal injury.
Smith SL; Scherch HM; Hall ED
J Neurosurg; 1996 Feb; 84(2):229-33. PubMed ID: 8592225
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of tirilazad mesylate (U-74006F), mannitol, and their combination on experimental ischemia.
Oktem IS; Menkü A; Akdemir H; Kontaş O; Kurtsoy A; Koç RK
Res Exp Med (Berl); 2000 Feb; 199(4):231-42. PubMed ID: 10743681
[TBL] [Abstract][Full Text] [Related]
18. Studies of ischemia-reperfusion injury in skeletal muscle: efficacy of 21-aminosteroids on microcirculation and muscle contraction after an extended period of warm ischemia.
Korompilias AV; Chen LE; Seaber AV; Urbaniak JR
J Orthop Res; 1997 Jul; 15(4):512-8. PubMed ID: 9379260
[TBL] [Abstract][Full Text] [Related]
19. Protection against postischemic spinal cord injury using a new 21-aminosteroid.
Fowl RJ; Patterson RB; Gewirtz RJ; Anderson DK
J Surg Res; 1990 Jun; 48(6):597-600. PubMed ID: 2362420
[TBL] [Abstract][Full Text] [Related]
20. Effect of the 21-aminosteroid tirilazad on cerebral pH and somatosensory evoked potentials after incomplete ischemia.
Maruki Y; Koehler RC; Kirsch JR; Blizzard KK; Traystman RJ
Stroke; 1993 May; 24(5):724-30. PubMed ID: 8488529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
